Terms: = Liver cancer AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492
8 results:
1. "Safety and utility of percutaneous liver biopsy in hematopoietic stem cell transplant pediatric recipients: a retrospective study".
Maximova N; Gregori M; Barbieri F; Pizzol A; Sonzogni A
BMC Cancer; 2016 Aug; 16():590. PubMed ID: 27485733
[TBL] [Abstract] [Full Text] [Related]
2. The calm before the storm: a report from the International liver cancer Association Congress 2015 - part 2.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):285-8. PubMed ID: 26776157
[TBL] [Abstract] [Full Text] [Related]
3. The calm before the storm: a report from the International liver cancer Association Congress 2015--part 1.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):281-4. PubMed ID: 26775918
[TBL] [Abstract] [Full Text] [Related]
4. [A study of "sudden death" in end-stage cancer patients receiving home care].
Suzuki M; Ishimaki S; Yamazaki F
Gan To Kagaku Ryoho; 2013 Dec; 40 Suppl 2():170-2. PubMed ID: 24712135
[TBL] [Abstract] [Full Text] [Related]
5. [Modern pharmacodynamics research and clinic application of huangqintang].
Zhang BG; Liang XX; Liu QF
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2587-90. PubMed ID: 19216147
[TBL] [Abstract] [Full Text] [Related]
6. Paclitaxel (taxol) inhibits the arylamine N-acetyltransferase activity and gene expression (mRNA NAT1) and 2-aminofluorene-DNA adduct formation in human bladder carcinoma cells (T24 and TSGH 8301).
Yang CC; Chen GW; Lu HF; Wang DY; Chen YS; Chung JG
Pharmacol Toxicol; 2003 Jun; 92(6):287-94. PubMed ID: 12787261
[TBL] [Abstract] [Full Text] [Related]
7. Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
Dougherty TB; Mikolajek JA; Curley SA
J Clin Anesth; 1997 May; 9(3):220-7. PubMed ID: 9172030
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01.
Stillwagon GB; Order SE; Guse C; Leibel SA; Asbell SO; Klein JL; Leichner PK
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):65-71. PubMed ID: 1847127
[TBL] [Abstract] [Full Text] [Related]
